title: Need for estradiol assays with a lower functional sensitivity in clinical studies examining postmenopausal women treated with aromatase inhibitors.
authors.forename: Steven
authors.initials: S
authors.lastname: Pauwels
authors.forename: Anneleen
authors.initials: A
authors.lastname: Lintermans
authors.forename: Patrick
authors.initials: P
authors.lastname: Neven
authors.forename: Johan
authors.initials: J
authors.lastname: Verhaeghe
authors.forename: Ivo
authors.initials: I
authors.lastname: Jans
authors.forename: Jaak
authors.initials: J
authors.lastname: Billen
authors.forename: Dirk
authors.initials: D
authors.lastname: Vanderschueren
authors.forename: Pieter
authors.initials: P
authors.lastname: Vermeersch
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology*; D047072:Aromatase Inhibitors / Q000494:pharmacology*; D015992:Body Mass Index; D001943:Breast Neoplasms / Q000097:blood* / Q000188:drug therapy*; D004967:Estrogens / Q000097:blood*; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000097:blood*; D009570:Nitriles / Q000494:pharmacology*; D014230:Triazoles / Q000494:pharmacology*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D004967:Estrogens; D009570:Nitriles; D014230:Triazoles